ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DHC vs JPM // OPERATING MARGIN

Diversified Healthcare Trust of (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: DHC 1 — JPM 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DHC VS. JPM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DHC JPM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.20% 17.72% -34.92 JPM /roic <GO>
EV/EBITDA & P/E Valuation — 9.5x — TIE /valuation <GO>
Free Cash Flow Yield -1.02% -9.41% +8.39 DHC /fcf-yield <GO>
Operating Margin ACTIVE — 41.98% — TIE /operating-margins <GO>
Net Profit Margin -18.60% 32.48% -51.08 JPM /net-margins <GO>
Revenue Growth (YoY) 2.80% 13.23% -10.43 JPM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.50% 1.95% -1.45 JPM /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.37 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 JPM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — 4.78% — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.7 53.6 -4.90 JPM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.00 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 13.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.87B $905.33B -$903.45B JPM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DHC REV JPM REV DHC GROSS % JPM GROSS % DHC FCF JPM FCF
FY 2025 $1.54B $182.45B — — -$19.6M -$147.78B
FY 2024 $1.50B $177.56B — — $112.2M -$42.01B
FY 2023 $1.41B $158.10B — — $10.5M $12.97B
FY 2022 — $128.69B — — — $107.12B
FY 2021 — $121.65B — — — $78.08B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DHC // BETA —
JPM // BETA 1.00